Related Experiment Video
Updated: Nov 10, 2025

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
Trans-conjunctival Erosion of a Novel SIBS Microshunt After Revision Surgery Using Mitomycin C
Luke Michaels1, Lee Holland1, Karl Mercieca1,2
1Manchester Royal Eye Hospital, Manchester, UK.
Abstract:
This article describes the first reported case of trans-conjunctival Preserflo microshunt erosion after revision surgery augmented with mitomycin C. Recommendations to avoid this complication include removal of original microshunt and limiting secondary application of mitomycin C.
Insights
This case report details the first instance of trans-conjunctival Preserflo microshunt erosion following revision surgery with mitomycin C. To prevent this, surgeons should remove the initial microshunt and use mitomycin C sparingly in secondary procedures.
Area of Science:
- Ophthalmology
- Surgical Innovation
Background:
- Glaucoma surgeries aim to reduce intraocular pressure.
- Preserflo microshunt is a device used in glaucoma surgery.
- Revision surgeries may be necessary for suboptimal outcomes.
Purpose of the Study:
- To report the first case of trans-conjunctival Preserflo microshunt erosion.
- To identify risk factors and propose preventative measures for this complication.
Main Methods:
- Case report of a patient undergoing revision glaucoma surgery.
- Detailed description of surgical technique and intraoperative findings.
- Histopathological examination of the eroded microshunt.
Main Results:
- The patient experienced trans-conjunctival Preserflo microshunt erosion post-revision surgery.
- Mitomycin C was used during the revision procedure.
- Erosion occurred at the site of the original microshunt.
Conclusions:
- Revision glaucoma surgery with mitomycin C carries a risk of microshunt erosion.
- Complete removal of the prior microshunt is recommended before revision.
- Judicious use of mitomycin C in secondary procedures may mitigate this risk.

